Arkolith/Insider Trading/RARE/Form 4

Parschauer Karah Herdman

EVP and Chief Legal OfficerUltragenyx Pharmaceutical Inc. (RARE) · full profile →Form 4 · filed Sep 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$76K
Net Open-Market Flow
-$76K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2025Sell(S)2K$31.17$76K73K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001677455-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML